Table 1.
Characteristics of the 115 patients included in the AMA-AC program
| Patient characteristics at diagnosis/entry to AMA-AC | (n = 115) |
|---|---|
| Gender Men (n;%) | 64 (55.7 %) |
| Age (years) | |
| Mean (Min; Max) | 55.0 (22.0; 87.0) |
| Median | 58 |
| Health insurance (n;%) | |
| General health system | 104 (90.4 %) |
| Others (Agriculture, freelancers) | 11 (9.6 %) |
| Cohabiting status (n;%) | |
| Living together (married, living in partnership) | 87 (75.6 %) |
| Living alone (single, divorced, widowed) | 28 (24.4 %) |
| Level of education (n;%) | |
| Lower educational status (≤high school degree) | 64 (55.7 %) |
| Higher educational status (>high school degree) | 51 (44.4 %) |
| Occupational status (n;%) | |
| In activity (employed) | 61 (53.0 %) |
| Without activity (without employment, retired, unemployed) | 54 (47.0 %) |
| Salary net/month (n;%) (n = 86) | |
| No salary | 3 (3.5 %) |
| <380€ - 1070€ | 20 (23.3 %) |
| >1070€ - 1830€ | 24 (27.9 %) |
| >1830€ - 2290€ | 12 (14.0 %) |
| >2290€ - 4570€ | 27 (31.4 %) |
| Disease-related characteristics | |
| Histology (n;%) | |
| Diffuse large B-cell lymphoma (DLBCL) | 64 (55.7 %) |
| Other NHL | 33 (28.6 %) |
| Hodgkin lymphoma | 18 (15.7 %) |
| Ann Arbor stage (n;%) (n = 112) | |
| I/ II | 25 (22.3 %) |
| III/ IV | 87 (77.7 %) |
| Performance status (n;%) | |
| ≤ 1 | 96 (83.5 %) |
| ≥ 2 | 19 (16.5 %) |
| Charlson comorbidity index (n;%) | |
| 0 | 88 (76.5 %) |
| 1 | 9 (7.8 %) |
| ≥ 2 | 18 (15.7 %) |
| Prognosis (according to IPI, FLIPI, IPS) (n = 112) | |
| Good | 19 (16.52 %) |
| Medium | 59 (51.30 %) |
| Bad | 24 (20.87 %) |
| Treatment-related characteristics | |
| Type of treatment line (n;%)a | |
| Conventional | 84 (73.0 %) |
| Intensified | 31 (27.0 %) |
Abbreviations: IPI International Prognostic Index; FLIPI Follicular Lymphoma International Prognostic Index; IPS International Prognostic Score (Hasenclever Index)
aType of treatment line: Conventional: CHOP21: 4 (3.5 %), R-CHOP21: 65 (56.5 %), R-mini-CHOP: 3 (2.6 %), ABVD: 12 (10.4 %); Intensified: R-ACVBP: 24 (20.9 %), R-COPADM: 1 (0.9 %), BEACOPP: 6 (5.2 %)